The Czech Republic has one of the highest incidences of colorectal cancer (CRC) in Europe. To evaluate whether sporadic CRCs in Czech patients have specific mutational profiles we analysed somatic genetic changes in known CRC genes (APC, KRAS, TP53, CTNNB1, MUTYH and BRAF, loss of heterozygosity (LOH) at the APC locus, microsatellite instability (MSI), and methylation of the MLH1 promoter) in 103 tumours from 102 individuals. The most frequently mutated gene was APC (68.9% of tumours), followed by KRAS (31.1%), TP53 (27.2%), BRAF (8.7%) and CTNNB1 (1.9%). Heterozygous germline MUTYH mutations in 2 patients were unlikely to contribute to the development of their CRCs. LOH at the APC locus was found in 34.3% of tumours, MSI in 24.3% and MLH1 methylation in 12.7%. Seven tumours (6.9%) were without any changes in the genes tested. The analysis yielded several findings possibly specific for the Czech cohort. Somatic APC mutations did not cluster in the mutation cluster region (MCR). Tumours with MSI but no MLH1 methylation showed earlier onset and more severe mutational profiles compared to MSI tumours with MLH1 methylation. TP53 mutations were predominantly located outside the hot spots, and transitions were underrepresented. Our analysis supports the observation that germline MUTYH mutations are rare in Czech individuals with sporadic CRCs. Our findings suggest the influence of specific ethnic genetic factors and/or lifestyle and dietary habits typical for the Czech population on the development of these cancers.

Department of Biology and Medical Genetics Charles University 2nd Faculty of Medicine and University Hospital Motol Prague Czech Republic

Zobrazit více v PubMed

Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18:581–592. PubMed

Bodmer WF. Cancer genetics: colorectal cancer as a model. J Hum Genet. 2006;51:391–396. PubMed PMC

Aretz S. The differential diagnosis and surveillance of hereditary gastrointestinal polyposis syndromes. Dtsch Arztebl Int. 2010;107:163–173. PubMed PMC

Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, et al. Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors. Nat Genet. 2002;30:227–232. PubMed

Poulsen ML, Bisgaard ML. MUTYH Associated Polyposis (MAP). Curr Genomics. 2008;9:420–435. PubMed PMC

Sulova M, Zidkova K, Kleibl Z, Stekrova J, Kebrdlova V, et al. Mutation analysis of the MYH gene in unrelated Czech APC mutation-negative polyposis patients. Eur J Cancer. 2007;43:1617–1621. PubMed

Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet. 1992;1:229–233. PubMed

Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, et al. Clues to the pathogenesis of familial colorectal cancer. Science. 1993;260:812–816. PubMed

Kitaeva MN, Grogan L, Williams JP, Dimond E, Nakahara K, et al. Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. Cancer Res. 1997;57:4478–4481. PubMed

Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res. 1998;58:1130–1134. PubMed

Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–767. PubMed

Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994;54:4855–4878. PubMed

de la Chapelle A, Hampel H. Clinical relevance of microsatellite instability in colorectal cancer. J Clin Oncol. 2010;28:3380–3387. PubMed PMC

Deng G, Bell I, Crawley S, Gum J, Terdiman JP, et al. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin Cancer Res. 2004;10:191–195. PubMed

Samowitz WS, Slattery ML, Sweeney C, Herrick J, Wolff RK, et al. APC mutations and other genetic and epigenetic changes in colon cancer. Mol Cancer Res. 2007;5:165–170. PubMed

Pritchard CC, Grady WM. Colorectal cancer molecular biology moves into clinical practice. Gut. 2011;60:116–129. PubMed PMC

Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002;30:3894–3900. PubMed PMC

Berg KD, Glaser CL, Thompson RE, Hamilton SR, Griffin CA, et al. Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. J Mol Diagn. 2000;2:20–28. PubMed PMC

Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev. 2009;18:1688–1694. PubMed

Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, et al. APC mutations occur early during colorectal tumorigenesis. Nature. 1992;359:235–237. PubMed

Lamlum H, Ilyas M, Rowan A, Clark S, Johnson V, et al. The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nat Med. 1999;5:1071–1075. PubMed

Rowan AJ, Lamlum H, Ilyas M, Wheeler J, Straub J, et al. APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci U S A. 2000;97:3352–3357. PubMed PMC

Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science. 1997;275:1784–1787. PubMed

Farrington SM, Tenesa A, Barnetson R, Wiltshire A, Prendergast J, et al. Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet. 2005;77:112–119. PubMed PMC

Isidro G, Laranjeira F, Pires A, Leite J, Regateiro F, et al. Germline MUTYH (MYH) mutations in Portuguese individuals with multiple colorectal adenomas. Hum Mutat. 2004;24:353–354. PubMed

Jenkins MA, Croitoru ME, Monga N, Cleary SP, Cotterchio M, et al. Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study. Cancer Epidemiol Biomarkers Prev. 2006;15:312–314. PubMed

Lubbe SJ, Di Bernardo MC, Chandler IP, Houlston RS. Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol. 2009;27:3975–3980. PubMed

Peterlongo P, Mitra N, Chuai S, Kirchhoff T, Palmer C, et al. Colorectal cancer risk in individuals with biallelic or monoallelic mutations of MYH. Int J Cancer. 2005;114:505–507. PubMed

Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein, et al. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature. 2002;418:934. PubMed

Thibodeau SN, French AJ, Cunningham JM, Tester D, Burgart LJ, et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res. 1998;58:1713–1718. PubMed

Samowitz WS, Curtin K, Wolff RK, Tripp SR, Caan BJ, et al. Microsatellite instability and survival in rectal cancer. Cancer Causes Control. 2009;20:1763–1768. PubMed PMC

Kim YH, Min BH, Kim SJ, Choi HK, Kim KM, et al. Difference between proximal and distal microsatellite-unstable sporadic colorectal cancers: analysis of clinicopathological and molecular features and prognoses. Ann Surg Oncol. 2010;17:1435–1441. PubMed

Oliveira C, Velho S, Moutinho C, Ferreira A, Preto A, et al. KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression. Oncogene. 2007;26:158–163. PubMed

de Vogel S, Weijenberg MP, Herman JG, Wouters KA, de Goeij AF, et al. MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events. Ann Oncol. 2009;20:1216–1222. PubMed

Domingo E, Espin E, Armengol M, Oliveira C, Pinto M, et al. Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation. Genes Chromosomes Cancer. 2004;39:138–142. PubMed

Huang J, Papadopoulos N, McKinley AJ, Farrington SM, Curtis LJ, et al. APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci U S A. 1996;93:9049–9054. PubMed PMC

Knai C, Suhrcke M, Lobstein T. Obesity in Eastern Europe: an overview of its health and economic implications. Econ Hum Biol. 2007;5:392–408. PubMed

Jackson MA, Lea I, Rashid A, Peddada SD, Dunnick JK. Genetic alterations in cancer knowledge system: analysis of gene mutations in mouse and human liver and lung tumors. Toxicol Sci. 2006;90:400–418. PubMed

Sugimura T, Wakabayashi K, Nakagama H, Nagao M. Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci. 2004;95:290–299. PubMed PMC

Phillips DH. Polycyclic aromatic hydrocarbons in the diet. Mutat Res. 1999;443:139–147. PubMed

Kazerouni N, Sinha R, Hsu CH, Greenberg A, Rothman N. Analysis of 200 food items for benzo[a]pyrene and estimation of its intake in an epidemiologic study. Food Chem Toxicol. 2001;39:423–436. PubMed

Dofkova M, Kopriva V, Resova D, Rehurkova I, Ruprich J. The development of food consumption in the Czech Republic after 1989. Public Health Nutr. 2001;4:999–1003. PubMed

Pardini B, Naccarati A, Novotny J, Smerhovsky Z, Vodickova L, et al. DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat Res. 2008;638:146–153. PubMed

Biggs PJ, Warren W, Venitt S, Stratton MR. Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the aetiology of cancer. Mutagenesis. 1993;8:275–283. PubMed

Smith G, Carey FA, Beattie J, Wilkie MJ, Lightfoot TJ, et al. Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci U S A. 2002;99:9433–9438. PubMed PMC

Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87:159–170. PubMed

Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut. 2004;53:1137–1144. PubMed PMC

Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005;352:1851–1860. PubMed

Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, et al. Patterns of somatic mutation in human cancer genomes. Nature. 2007;446:153–158. PubMed PMC

Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, et al. The genomic landscapes of human breast and colorectal cancers. Science. 2007;318:1108–1113. PubMed

Leary RJ, Lin JC, Cummins J, Boca S, Wood LD, et al. Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc Natl Acad Sci U S A. 2008;105:16224–16229. PubMed PMC

Molecular characteristics of mismatch repair genes in sporadic colorectal tumors in Czech patients

Unique mutational profile associated with a loss of TDG expression in the rectal cancer of a patient with a constitutional PMS2 deficiency